Editorial: Serum fibrosis markers: Death by validation or a leap of faith?

Journal of Hepatology

Volumn 53, Issue 2, 2010, Pages 222-224

  Ratziu, Vlad ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; ALPHA 2 MACROGLOBULIN; ASPARTATE AMINOTRANSFERASE; PROTHROMBIN;

BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EDITORIAL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; MIXED INFECTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; BIOPSY; BLOOD; COMORBIDITY; LIVER; LIVER CIRRHOSIS; METABOLISM; NOTE; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

ALPHA-MACROGLOBULINS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; COMORBIDITY; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; PROTHROMBIN; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77955307929     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.04.006     Document Type: Editorial

References (17)

1. T. Poynard, A. Aubert, P. Bedossa, A. Abella, S. Naveau, and F. Paraf A simple biological index for detection of alcoholic liver disease in drinkers Gastroenterology 100 1991 1397 1402
2. F. Oberti, E. Valsesia, C. Pilette, M.C. Rousselet, P. Bedossa, and C. Aube Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
3. V. Ratziu, P. Giral, F. Charlotte, E. Bruckert, V. Thibault, and I. Theodorou Liver fibrosis in overweight patients Gastroenterology 118 2000 1117 1123
4. P. Cales, F. Oberti, S. Michalak, I. Hubert-Fouchard, M.C. Rousselet, and A. Konate A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 2005 1373 1381
5. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, and T. Poynard Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
6. P. Cales, J. Boursier, F. Oberti, I. Hubert, Y. Gallois, and M.C. Rousselet FibroMeters: a family of blood tests for liver fibrosis Gastroenterol Clin Biol 32 2008 40 51
7. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457 (Pubitemid 37466971)
8. S.H. Mehta, B. Lau, N.H. Afdhal, and D.L. Thomas Exceeding the limits of liver histology markers J Hepatol 50 2009 36 41
9. F. Imbert-Bismut, D. Messous, V. Thibaut, R.B. Myers, A. Piton, and D. Thabut Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Clin Chem Lab Med 42 2004 323 333
10. T. Poynard, M. Muntenau, R. Morra, Y. Ngo, F. Imbert-Bismut, and D. Thabut Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update Gastroenterol Clin Biol 32 2008 8 21
11. T. Poynard, M. Munteanu, F. Imbert-Bismut, F. Charlotte, D. Thabut, and S. Le Calvez Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
12. Y. Ngo, M. Munteanu, D. Messous, F. Charlotte, F. Imbert-Bismut, and D. Thabut A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C Clin Chem 52 2006 1887 1896
13. Y. Ngo, Y. Benhamou, V. Thibault, P. Ingiliz, M. Munteanu, and P. Lebray An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load PLoS One 3 2008 e2573
14. S. Naveau, G. Gaude, A. Asnacios, H. Agostini, A. Abella, and N. Barri-Ova Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease Hepatology 49 2009 97 105
15. M.J. Mayo, J. Parkes, B. Adams-Huet, B. Combes, A.S. Mills, and R.S. Markin Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay Hepatology 48 2008 1549 1557
16. T. Poynard, Y. Ngo, P. Marcellin, S. Hadziyannis, V. Ratziu, and Y. Benhamou Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus J Viral Hepat 16 2009 203 213
17. G. Sebastiani, A. Vario, M. Guido, F. Noventa, M. Plebani, and R. Pistis Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C J Hepatol 44 2006 686 693